Northwest Biotherapeutics Overview
Founded
1996
Status
Public
Employees
17
Stock Symbol
NWBO
Investments
1
Share Price
$0.34
(As of Wednesday Closing)
Northwest Biotherapeutics General Information
Description
Northwest Biotherapeutics Inc is a biotechnology company involved in the development of cancer vaccines. The target is a broad range of solid-tumor cancers. The company has a proprietary manufacturing technology, which it uses to produce a personalized vaccine. The product portfolio includes product candidates such as DCVax-L, for patients with brain cancer; DCVax-Direct, direct injection into all types of inoperable solid tumor cancers, and DCVax for late-stage ovarian cancer. DCVax-Prostate, for late-stage prostate cancer, has received clearance from the U.S. Food and Drug Administration.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
PINX
Primary Office
- 4800 Montgomery Lane
- Suite 800
- Bethesda, MD 20814
- United States
+1 (240) 000-0000
Northwest Biotherapeutics Stock Performance
(As of Tuesday closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.34 | $0.32 | $0.14 - $0.42 | $213M | 660M | 2.22M | -$0.05 |
Northwest Biotherapeutics Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2019 | FY 2018 31-Dec-2018 | FY 2017 31-Dec-2017 | FY 2016 31-Dec-2016 |
|---|---|---|---|---|
| EV | 156,185 | 137,122 | 100,252 | 73,141 |
| Revenue | 0 | 0 | 0 | 0 |
| EBITDA | (28,024) | (24,632) | (67,159) | (76,207) |
| Net Income | (32,619) | (35,794) | (73,143) | (80,214) |
| Total Assets | 10,145 | 24,667 | 48,907 | 52,906 |
| Total Debt | 18,551 | 16,797 | 31,429 | 31,711 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Northwest Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.
Request a free trial
Northwest Biotherapeutics Competitors (42)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | Corporate Backed or Acquired | Boston, MA | 0 | 00.000 | 000000000 | 00.000 |
| 000 000000000000 | Formerly VC-backed | Epalinges, Switzerland | 000 | 00000 | 00000000 | 00000 |
| 000000000 | Venture Capital-Backed | Gaithersburg, MD | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 | Formerly PE-Backed | Beijing, China | 0000 | 00.000 | 000000000 | 00.000 |
| 0000000 00000000 | Formerly VC-backed | Bothell, WA | 0000 | 00000 | 000000 - 000 | 00000 |
Northwest Biotherapeutics Executive Team (7)
4 Former Executives
Northwest Biotherapeutics Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000000000 | Northwest Biotherapeutics | Board Member | 000 0000 |
| 0000000 000000000 | Self | Director | 000 0000 |
3 Former Board Members
Northwest Biotherapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Northwest Biotherapeutics‘s full profile, request access.
Request a free trial
Northwest Biotherapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 01-Jan-2008 | 000000000000000000 | Biotechnology |
Ready to get started?
Request a free trial